$MJ Why President Trump Will Leave Legal Marijuana Alone

New Post Public Reply Private Reply Replies (0) Message Board
mc67
346
$MJ Why President Trump Will Leave Legal Marijuana Alone https://shar.es/1RcjTe

Why President Trump Will Leave Legal Marijuana Alone

Protected By The Rohrabacher-Farr Amendment And Rising In Popularity

Posted by Reginald Reefer on Friday May 26, 2017


Personally, I hate talking about Trump. However, today we have to do so since Trump did say some pretty ‘aggressive’ things about cannabis and the cannabis industry.
 
 
This right after Congress essentially tied up Jeff Sessions’ hands in relation to prosecuting legal medical marijuana businesses in states that have legalized it. This comes under a rider that was introduced and signed by Trump known as the Rohrabacher-Farr Amendment. Meaning, it is the law right now.
 
 
What does the Rohrabacher-Farr Amendment imply?

While there are a few bills circulating the political arena that would grant full legalization of cannabis, it isn’t likely that it will pass any time soon. Thus, Congress-people use budgetary bills to slip in pro-cannabis policy as is the case of the Rohrabacher-Farr Amendment.
 
 
Essentially, this rider means that the DOJ and the DEA are barred from using federal funds to prosecute medical marijuana businesses in places that legalized it. In other words, federal laws against marijuana is still on the books, the DOJ just can’t use any money to enforce them.
 
 
As you can imagine, the cannabis industry touted this as a great victory, until Trump had to release a signing statement that read;
 
 
“I will treat this provision [the R-F Amendment] consistently with my constitutional responsibility to take care that the laws be faithfully executed,”
 
 
While this doesn’t mean he’s outright saying, “I’m going to ignore this”, it does leave wiggle room for him to do so if he chooses. After all, he is right in everything he said.
 
 
The only problem is that the President of the US doesn’t have power of the Federal Purse, that is the responsibility of Congress. So even if he goes full on “drug warrior” on legal cannabis, he still would have to take it to a Federal court and win. This seems to be a difficult task since the 9th district court upheld the validity of the rider.
 
 
Can Trump still push back?
 
 
Of course he can, however the question that we should be asking is, “will he?” Trump has a lot on his plate and to tackle cannabis, which is the fastest growing political issue in the US, going against the will of the people is ill-advised.
 
You see, for the last three presidential elections, cannabis has outdone all the candidates in terms of popularity. There are 28 states and the District of Columbia that have legal cannabis systems in place. The industry is generating billions of dollars each year and creating thousands of new jobs.
 
 
Can you imagine what would happen if Trump were to piss off the cannabis industry as a whole? You’d have nearly half of the entire population in the US rising up against it.
 
 
People are sick and tired of the war on drugs and for Trump to re-ignite it would be a massive political mistake. I would even argue that it could get him removed from the Presidency seeing that millions of people rely on it now.
 
 
Not only is legal cannabis reducing the spending on Medicaid, it’s helping curb an opioid epidemic as well as generating new income for states that have legalized.
 
 
Cannabis is a Subject that Embarks a lot!

You have to understand that cannabis isn’t about smoking weed only. It’s about healthcare, job creation, reduction of stress on the justice system, new revenue streams, human rights, discrimination against minorities and so much more.
 
 
The government wants you to believe that this subject is just about weed, however we all know that cannabis has intricately placed itself in the middle of many social issues. Even if you don’t smoke marijuana, it still affects you whether it’s legal or not.
 
 
Thus, cannabis is a very difficult topic to simply “uproot”, especially since we have already witnessed a failed attempt at prohibiting the substance. People now have the insight to see that the current approach of the government isn’t working.
 
 
Hell, in states that have legalized, teens aren’t consuming more. Traffic fatalities are dropping. Overdoses on Opioids are dropping. We’re seeing way more benefits than any potential risk that was sold to us over the years.
 
 
Then comes the medical aspect of cannabis. People getting treated with the plant from Seizure Disorders, cancer, IBS, autoimmune disorders, pain management, psychological issues and much more. If you assault cannabis, you assault all of these people and we know that within any great cause, martyrs are usually the elements that sway public opinion in favor of the cause.
 
 
So Trump goes and takes away medicine from a baby with 300 seizures a week, you can rest assured that that scenario is a political nightmare. You know how they say taking candy from a baby is bad…well, taking lifesaving medicine from infants is way worse. 

Trump will not do anything
 
 
I don’t think Trump will be dumb enough to tackle the cannabis industry. We have grown significantly over the past few years and nowadays cannabis is no longer a fringe topic. It’s starting to get center stage and the people of the World have spoken; We want it all and we want it now!
  (cont'd) ..click link for pics/graphs

Read More: https://investorshangout.com/post/view?id=457...z4liKZlYwP
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading